05:52 PM EDT, 06/04/2024 (MT Newswires) -- Cellectis ( CLLS ) said late Tuesday that the European Commission has granted an orphan drug designation to the company's product candidate UCART22 to treat acute lymphoblastic leukemia. The European Medicines Agency considered the significant benefit of UCART22 has been demonstrated based on the preliminary data generated with UCART22 in heavily pretreated patients...

05:51 PM EDT, 06/04/2024 (MT Newswires) -- David A Preiser, Director, Co-President, on June 04, 2024, sold 20,000 shares in Houlihan Lokey ( HLI ) for $2,664,200. SEC Filing: https://www.sec.gov/Archives/edgar/data/1302215/000130221524000075/xslF345X03/wk-form4_1717537597.xml ...

05:53 PM EDT, 06/04/2024 (MT Newswires) -- Phunware ( PHUN ) said late Tuesday that it is seeking regulatory clearance to sell up to $120 million of its shares through an at-the-market offering. The company, which has filed a prospectus supplement to its existing shelf registration statement, said that no additional capacity is being added to the registration statement as...

05:53 PM EDT, 06/04/2024 (MT Newswires) -- Zevra Therapeutics ( ZVRA ) filed a shelf registration statement with the US Securities and Exchange Commission Tuesday covering the potential sale of up to $350 million of its securities from time to time in one or more offerings. The statement covers the company's common and preferred shares, debt securities and warrants, according...